No Data
No Data
Aclaris Therapeutics Upgraded to Buy From Hold at Jefferies
Aclaris Therapeutics Upgraded to Buy From Neutral at BTIG
This Healthcare Stock Is Soaring Following Exclusive License Agreement Announcement
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Aclaris Therapeutics Shares Soar After Multiple Analyst Upgrades
Aclaris Therapeutics Up 53%; Analysts' Target Boosts Follow Monday License News